PagodaTree Partners is a Beijing-based private equity fund manager founded in 2019 that invests in healthcare, biotech, technology and frontier interdisciplinary opportunities with an ESG-oriented, research-driven approach. The firm backs early-stage and later-stage/growth companies across China and the United States, with sector relevance in biotechnology, life sciences, oncology, pharmaceuticals, medical devices, HealthTech, TMT and deep tech.